Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03442582 · ClinicalTrials.gov registry record
Afluria Pregnancy Registry
A clinical trial, sponsored by Seqirus.
- Completed
- Registry status
- 490
- Enrollment target
NCT03442582 is a clinical trial that has completed, run by Seqirus. The registered enrollment target is 490 participants.
The verdict
NCT03442582 has completed, sponsored by Seqirus.
- COMPLETED
- Registry status
- 490 participants
- Enrollment target
Study Summary
The study is a population based prospective cohort study designed to collect data on pregnancy outcomes and events of interest among women immunized with Afluria during pregnancy.
Interventions
- BIOLOGICAL Afluria Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2017-09-08 |
| Est. Completion | 2021-09-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03442582
The ClinicalTrials.gov registry entry for NCT03442582 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 490 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seqirus, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Afluria Influenza Vaccine is the first listed.
NCT03442582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03442582 about?
NCT03442582 is a clinical study titled "Afluria Pregnancy Registry". The study is a population based prospective cohort study designed to collect data on pregnancy outcomes and events of interest among women immunized with Afluria during pregnancy.
What is the current status of trial NCT03442582?
This trial is currently completed. The enrollment target is 490 participants. The study started on 2017-09-08. Estimated completion is 2021-09-14.
What interventions are being tested in trial NCT03442582?
The interventions under investigation include: Afluria Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT03442582?
This trial is sponsored by Seqirus, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.